Status: current, Defined. Date: 30-Nov 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4668450019 | Amlodipine and indapamide only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4668451015 | Product containing only amlodipine and indapamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amlodipine and indapamide only product in oral dose form | Is a | Amlodipine and indapamide only product | true | Inferred relationship | Some | ||
| Amlodipine and indapamide only product in oral dose form | Is a | Amlodipine- and indapamide-containing product in oral dose form | true | Inferred relationship | Some | ||
| Amlodipine and indapamide only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Amlodipine and indapamide only product in oral dose form | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Amlodipine and indapamide only product in oral dose form | Has active ingredient | Amlodipine | true | Inferred relationship | Some | 1 | |
| Amlodipine and indapamide only product in oral dose form | Has active ingredient | Indapamide | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Is a | True | Amlodipine and indapamide only product in oral dose form | Inferred relationship | Some | |
| Amlodipine (as amlodipine besilate) 5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Is a | True | Amlodipine and indapamide only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets